Chronic viral infections and immunosenescence, with a focus on CMV

Open Longevity Science

Volumn 6, Issue , 2012, Pages 33-38

  Tatum, Angela M ^a   Hill, Ann ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CD8 t cells; Cytomegalovirus; Immunosenescence

Indexed keywords

BIOLOGICAL MARKER; CD27 ANTIGEN; CD28 ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; MORTALITY; NATURAL KILLER CELL; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY;

EID: 84863915665     PISSN: None     EISSN: 1876326X     Source Type: Journal    
DOI: 10.2174/1876326X01206010033     Document Type: Article

References (49)

1. Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB. Vaccination in the elderly: an immunolog-ical perspective. Trends Immunol 2009; 30: 351-9.
2. Koch S, Larbi A, Ozcelik D, et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007; 1114:23-35.
3. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908:244-54.
4. Strindhall J, Nilsson BO, Lofgren S, et al. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 2007; 42:753-61.
5. Wikby A, Nilsson BO, Forsey R, et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 2006; 127:695-704.
6. Panda A, Arjona A, Sapey E, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009; 30:325-33.
7. Ongradi J, Kovesdi V. Factors that may impact on immunosenescence: an appraisal. Immun Ageing 2010; 7:7.
8. Zhang Y, Wallace DL, de Lara CM, et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 2007; 121:258-65.
9. Appay V, Sauce D, Prelog M. The role of the thymus in immunosenescence: lessons from the study of thymectomized indi-viduals. Aging (Albany NY) 2010; 2:78-81.
10. Naylor K, Li G, Vallejo AN, et al. The influence of age on T cell generation and TCR diversity. J Immunol 2005; 174:7446-52.
11. Fagnoni FF, Vescovini R, Passeri G, et al. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000; 95:2860-8.
12. Weinberger B, Lazuardi L, Weiskirchner I, et al. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007; 68:86-90.
13. Ferrando-Martinez S, Ruiz-Mateos E, Hernandez A, et al. Age-related deregulation of naive T cell homeostasis in elderly humans. Age (Dordr) 2011; 33(2): 197-207.
14. Mollet L, Sadat-Sowti B, Duntze J, et al. CD8hi+CD57+ T lym-phocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol 1998; 10:311-23.
15. Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 2009; 30:306-12.
16. Hintzen RQ, de Jong R, Lens SM, Brouwer M, Baars P, van Lier RA. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993; 151:2426-35.
17. Gupta S, Bi R, Su K, Yel L, Chiplunkar S, Gollapudi S. Characteri-zation of naive, memory and effector CD8+ T cells: effect of age. Exp Gerontol 2004; 39:545-50.
18. Zanni F, Vescovini R, Biasini C, et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship be-tween inflammation and immunosenescence. Exp Gerontol 2003; 38:981-7.
19. Lazuardi L, Herndler-Brandstetter D, Brunner S, Laschober GT, Lepperdinger G, Grubeck-Loebenstein B. Microarray analysis re-veals similarity between CD8+CD28- T cells from young and el-derly persons, but not of CD8+CD28+ T cells. Biogerontology 2009; 10:191-202.
20. Valenzuela HF, Effros RB. Divergent telomerase and CD28 ex-pression patterns in human CD4 and CD8 T cells following repeat-ed encounters with the same antigenic stimulus. Clin Immunol 2002; 105:117-25.
21. Effros RB. Telomerase induction in T cells: a cure for aging and disease? Exp Gerontol 2007; 42:416-20.
22. Dagarag M, Ng H, Lubong R, Effros RB, Yang OO. Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol 2003; 77:3077-83.
23. van de Berg PJ, Griffiths SJ, Yong SL, et al. Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol 2010; 184:3417-33.
24. Dagarag M, Evazyan T, Rao N, Effros RB. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and te-lomere length stabilization. J Immunol 2004; 173:6303-11.
25. Parish ST, Wu JE, Effros RB. Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lym-phocytes. J Clin Immunol 2010; 30:798-805.
26. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of immune respons-es to vaccines in elderly persons. Clin Infect Dis 2008; 46:1078-84.
27. Effros RB. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 2007; 25:599-604.
28. Saurwein-Teissl M, Lung TL, Marx F, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168:5893-9
29. Trzonkowski P, Mysliwska J, Szmit E, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vac-cination--an impact of immunosenescence. Vaccine 2003; 21:3826-36.
30. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39:687-99.
31. Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine produc-tion in mononuclear cells of healthy elderly people. Eur J Immunol 1993; 23:2375-8.
32. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Im-mune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 1995; 50:B378-82.
33. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Chang-es in CD8 and CD4 lymphocyte subsets, T cell proliferation re-sponses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998; 102:187-98.
34. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage pre-dicting mortality and an increased number of dysfunctional cyto-megalovirus-specific T cells in the very elderly. J Immunol 2006; 176:2645-53.
35. Sinclair J, Sissons P. Latency and reactivation of human cytomeg-alovirus. J Gen Virol 2006; 87:1763-79.
36. Gillespie GM, Wills MR, Appay V, et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lym-phocytes in healthy seropositive donors. J Virol 2000; 74:8140-50.
37. Lang KS, Moris A, Gouttefangeas C, et al. High frequency of human cytomegalovirus (HCMV)-specific CD8+ T cells detected in a healthy CMV-seropositive donor. Cell Mol Life Sci 2002; 59:1076-80.
38. Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202:673-85.
39. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
40. Vescovini R, Telera A, Fagnoni FF, et al. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp Gerontol 2004; 39:1233-43.
41. Castle SC. Impact of age-related immune dysfunction on risk of infections. Z Gerontol Geriatr 2000; 33:341-9.
42. Looney RJ, Falsey A, Campbell D, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999; 90:213-9.
43. van de Berg PJ, van Stijn A, Ten Berge IJ, van Lier RA. A finger-print left by cytomegalovirus infection in the human T cell com-partment. J Clin Virol 2008; 41:213-7.
44. Almanzar G, Schwaiger S, Jenewein B, et al. Long-term cytomeg-alovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbal-ance in the cytokine production profile in elderly persons. J Virol 2005; 79:3675-83.
45. Chidrawar S, Khan N, Wei W, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009; 155:423-32.
46. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169:1984-92.
47. Ouyang Q, Wagner WM, Wikby A, et al. Large numbers of dys-functional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 2003; 23:247-57.
48. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumu-late in the elderly. Exp Gerontol 2004; 39:607-13.
49. Faist B, Fleischer B, Jacobsen M. Cytomegalovirus infection- and age-dependent changes in human CD8+ T-cell cytokine expression patterns. Clin Vaccine Immunol 2010; 17:986-92.